Microbiology Spectrum, 2023 A novel oxazolidinone for the treatment of Mycobacterium tuberculosis has been developed, but the activity of contezolid (MRX-I) still needs to be clarified.
Huiru An +5 more
doaj +3 more sources
Health Technology Assessment of Oxazolidinones for MRSA-Associated Complicated Skin and Soft Tissue Infections [PDF]
Drug Design, Development and TherapyYucheng Zhao, Baisen Huang, Zunchang Yang, Hongjie Kuang, Jisheng Chen Key Specialty of Clinical Pharmacy, the First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, People’s Republic of ChinaCorrespondence: Jisheng Chen, Key ...
Zhao Y, Huang B, Yang Z, Kuang H, Chen J
doaj +2 more sources
Safety and Tolerability of Contezolid Versus Linezolid for Short-Term Treatment of Rifampicin-Resistant Pulmonary Tuberculosis: A Randomized Controlled Study [PDF]
Infection and Drug ResistanceJun Wang,* Yu Xue,* Wenjuan Nie, Liping Ma, Naihui Chu, Yadong Du Tuberculosis Department, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, People’s Republic of China&
Wang J, Xue Y, Nie W, Ma L, Chu N, Du Y
doaj +2 more sources
Frontiers in Medicine, 2023 BackgroundContezolid is a novel oxazolidinone antibacterial agent, but there have been no reports of any pertinent clinical studies for the treatment of tuberculosis (TB).
Jun Wang, Liping Ma
doaj +3 more sources
Successful Treatment of Intractable Tuberculous Peritonitis in a Woman with Chronic Kidney Allograft Dysfunction Using Contezolid Containing Regimen [PDF]
Infection and Drug ResistanceWeijian Liu,* Liangzi Yang,* Hongjuan Qin, Peize Zhang Department of Pulmonary Medicine and Tuberculosis, The Third People’s Hospital of Shenzhen, Shenzhen, Guangdong, People’s Republic of China*These authors contributed equally to this ...
Liu W, Yang L, Qin H, Zhang P
doaj +2 more sources
Frontiers in Medicine, 2023 Tuberculous meningitis (TBM) is the most common form of central nervous system tuberculosis (TB) and the most severe form of extrapulmonary TB. It often presents with non-specific symptoms initially and has a high mortality and disability rate. With good
Zhe Xu +6 more
doaj +3 more sources
Current Status and Perspectives of Antibacterial Agents Belonging to 2-Oxazolidinones [PDF]
PharmaceuticalsIn the last three decades, 2-oxazolidinones have emerged as an important class of inhibitors of bacterial protein synthesis, effective in the treatment of multidrug-resistant (MDR) bacterial infections. From a public health perspective, the importance of
Jessica Ceramella +9 more
doaj +2 more sources
Advances in Therapeutic Drug Monitoring and Pharmacokinetic Researches of Oxazolidinone Antibacterial Agents in the Elderly Patients [PDF]
Clinical Interventions in AgingTingting Liu,1,2,* Zeyang Li,1,2,* Ge Wei,3,* Yang Yang,1 Fang Wang,1 Yue Wang,1 Keke Kang,1 Ping Yang,1 Hongxia Li,1 Bing Liu,4 Xiangqun Fang1 1Department of Pulmonary and Critical Care Medicine, The Second Medical Center & ...
Liu T +10 more
doaj +2 more sources
Safety and Effectiveness of Contezolid versus Linezolid in Drug-Resistant Tuberculosis: A 12-Month Retrospective Study from China [PDF]
Infection and Drug ResistanceYu Xiao,* Peng-Fei Huang,* Lei Xie, Lei Gao, Yi Han, Shuang Liu, Ya-Xue Liang, Yan-Jun Xiong, Hua Wang Department of Tuberculosis, Anhui Provincial Chest Hospital (Anhui Institute of Tuberculosis Control), Hefei, Anhui, 230022, People’s ...
Xiao Y +8 more
doaj +2 more sources
Efficacy of Contezolid in the Treatment of Catheter-Related Bloodstream Infections Caused by Methicillin-Resistant Staphylococcus aureus in a Patient with Hepatorenal Syndrome and Acute Kidney Injury: A Case Report [PDF]
Infection and Drug ResistanceXiucui Zhang,* Huili Huang,* Jianrong Wang, Bo Wei Department of Infectious Disease, Changzheng Hospital, Navy Medical University, Shanghai, People’s Republic of China*These authors contributed equally to this workCorrespondence: Bo Wei ...
Zhang X, Huang H, Wang J, Wei B
doaj +2 more sources